High-Dose Ibuprofen in Cystic Fibrosis: Canadian Safety and Effectiveness Trial
To access this article, please choose from the options below
Supported by the Canadian Institutes of Health Research and the Canadian Cystic Fibrosis Foundation.L. Lands, R. Milner, and M. Corey all participated in the study design and the acquisition and interpretation of the data. A. Cantin participated in the study design. D. Manson performed the chest radiograph scoring. All authors read and approved the final version of the manuscript. L. Lands wrote the first draft and received no honorarium or payment of any kind.
PII: S0022-3476(07)00343-5
doi:10.1016/j.jpeds.2007.04.009
© 2007 Mosby, Inc. All rights reserved.
Refers to article:
- Non! to Non-Steroidal Anti-Inflammatory Therapy for Inflammatory Lung Disease in Cystic Fibrosis (at Least at the Moment)
